scholarly journals Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV

Circulation ◽  
2018 ◽  
Vol 138 (11) ◽  
pp. 1100-1112 ◽  
Author(s):  
Anoop S.V. Shah ◽  
Dominik Stelzle ◽  
Kuan Ken Lee ◽  
Eduard J. Beck ◽  
Shirjel Alam ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Global Burden ◽  
People Living With Hiv ◽  
Atherosclerotic Cardiovascular Disease ◽  
Living With Hiv

scholarly journals Elevated cardiac risk score by Atherosclerotic Cardiovascular Disease calculation is associated with albuminuria in older people living with HIV

AIDS ◽  
2020 ◽  
Vol 34 (6) ◽  
pp. 947-949
Author(s):  
Carrie D. Johnston ◽  
Kene-Chukwu C. Ifeagwu ◽  
Eugenia L. Siegler ◽  
Heather Derry ◽  
Chelsie O. Burchett ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Older People ◽  
Risk Score ◽  
Cardiac Risk ◽  
People Living With Hiv ◽  
Atherosclerotic Cardiovascular Disease ◽  
Living With Hiv

Assessment of atherosclerotic cardiovascular disease risks between people living with HIV receiving first-line and second-line antiretroviral therapy in a resource-limited setting

2021 ◽  
Vol 32 (5) ◽  
pp. 421-426
Author(s):  
Jaruwan Tiarukkitsagul ◽  
Somnuek Sungkanuparph
Keyword(s):  
Cardiovascular Disease ◽  
People Living With Hiv ◽  
Atherosclerotic Cardiovascular Disease ◽  
Second Line ◽  
First Line ◽  
Resource Limited ◽  
Ascvd Risk ◽  
The Mean ◽  
Living With Hiv ◽  
Limited Setting

Cardiovascular disease has become an important health problem in people living with HIV (PLHIV) who receive antiretroviral therapy (ART). Atherosclerotic cardiovascular disease (ASCVD) risk score is a non-invasive tool to estimate the 10-year risk for ASCVD. A cross-sectional study was conducted among PLHIV receiving ART in a resource-limited setting, in order to assess the 10-year ASCVD risk between PLHIV receiving first-line and second-line ART. Of 460 participants with a mean age of 51.2 years, 262 (57.0%) were men. The mean duration of HIV infection was 14.7 years and the mean CD4 cell count was 509 cells/μL. Of all, 345 participants were receiving first-line ART and 115 were receiving second-line ART. The median 10-year ASCVD risk was 3.0% and 5.1% in the first-line and second-line ART groups, respectively ( p = 0.029). The prevalence of a high 10-year ASCVD risk (≥20%) was significantly higher in the second-line ART group (3.5% vs 0.9%, p = 0.048). In multivariate analysis, receiving second-line ART was significantly associated with intermediate to high 10-year ASCVD risk (OR = 2.952; 95% CI, 1.656–6.997; p = 0.015). Atherosclerotic cardiovascular disease risk should be assessed in PLHIV, particularly those who receive second-line ART.

Patients Living With HIV Are Less Likely to Receive Appropriate Statin Therapy for Cardiovascular Disease Risk Reduction

2021 ◽  
pp. 089719002199979
Author(s):  
Roshni P. Emmons ◽  
Nicholas V. Hastain ◽  
Todd A. Miano ◽  
Jason J. Schafer
Keyword(s):  
Cardiovascular Disease ◽  
Logistic Regression ◽  
Statin Therapy ◽  
Risk Reduction ◽  
Blood Cholesterol ◽  
Control Group ◽  
Atherosclerotic Cardiovascular Disease ◽  
Ascvd Risk ◽  
Living With Hiv ◽  
To Receive

Background: Recent studies suggest that statins are underprescribed in patients living with HIV (PLWH) at risk for atherosclerotic cardiovascular disease (ASCVD), but none have assessed if eligible patients receive the correct statin and intensity compared to uninfected controls. Objectives: The primary objective was to determine whether statin-eligible PLWH are less likely to receive appropriate statin therapy compared to patients without HIV. Methods: This retrospective study evaluated statin eligibility and prescribing among patients in both an HIV and internal medicine clinic at an urban, academic medical center from June-September 2018 using the American College of Cardiology/American Heart Association guideline on treating blood cholesterol to reduce ASCVD risk. Patients were assessed for eligibility and actual treatment with appropriate statin therapy. Characteristics of patients appropriately and not appropriately treated were compared with chi-square testing and predictors for receiving appropriate statin therapy were determined with logistic regression. Results: A total of 221/300 study subjects were statin-eligible. Fewer statin-eligible PLWH were receiving the correct statin intensity for their risk benefit group versus the uninfected control group (30.2% vs 67.0%, p < 0.001). In the multivariable logistic regression analysis, PLWH were significantly less likely to receive appropriate statin therapy, while those with polypharmacy were more likely to receive appropriate statin therapy. Conclusion: Our study reveals that PLWH may be at a disadvantage in receiving appropriate statin therapy for ASCVD risk reduction. This is important given the heightened risk for ASCVD in this population, and strategies that address this gap in care should be explored.

scholarly journals Association Between Bilirubin, Atazanavir, and Cardiovascular Disease Events Among People Living With HIV Across the United States

2019 ◽  
Vol 81 (5) ◽  
pp. e141-e147 ◽  
Author(s):  
Heidi M. Crane ◽  
Robin M. Nance ◽  
Susan R. Heckbert ◽  
Corey Ritchings ◽  
Lisa Rosenblatt ◽  
...  
Keyword(s):  
United States ◽  
Cardiovascular Disease ◽  
The United States ◽  
People Living With Hiv ◽  
Living With Hiv

scholarly journals Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV

2019 ◽  
Vol 81 (5) ◽  
pp. 562-571 ◽  
Author(s):  
Rosan A. van Zoest ◽  
Matthew Law ◽  
Caroline A. Sabin ◽  
Ilonca Vaartjes ◽  
Marc van der Valk ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Risk Prediction ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Predictive Performance ◽  
People Living With Hiv ◽  
Prediction Algorithms ◽  
Living With Hiv

Triad of the Ischemic Cardiovascular Disease in People Living with HIV? Association Between Risk Factors, HIV Infection, and Use of Antiretroviral Therapy

2018 ◽  
Vol 20 (6) ◽  
Author(s):  
Hugo Ribeiro Zanetti ◽  
Edmar Lacerda Mendes ◽  
Antonio Carlos Palandri Chagas ◽  
Maria Odila Gomes Douglas ◽  
Leandro Teixeira Paranhos Lopes ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Antiretroviral Therapy ◽  
Hiv Infection ◽  
People Living With Hiv ◽  
Living With Hiv
Sign in / Sign up

Export Citation Format

Share Document